Vincristine is an antitumor vinca alkaloid isolated from Vinca Rosea. It is marketed under several brand names, many of which have different formulations including Marqibo (liposomal injection) and Vincasar. Vincristine is indicated to treat acute leukaemia, malignant lymphoma, Hodgkin’s disease, acute erythraemia, and acute panmyelosis. It is grouped under the following drug class(es): Microtubule inhibitors and Vinca alkaloids. Its therapeutic use is listed as anti-cancer agents. The directory classifies it as a commercial API with a natural source/manufacturing origin. Other names for this substance include Vinkristin and Leurocristine. Its PubChem CID is 5978.
Vincristine
| CAS No | 57-22-7 |
|---|---|
| Molecular Formula | C46H56N4O10 |
| Molecular Weight | 825.0 g/mol |
| Synonyms | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Vincristine is an antitumor vinca alkaloid isolated from Vinca Rosea. It is marketed under several brand names, many of which have different formulations including Marqibo (liposomal injection) and Vincasar.
The listed CAS number is 57-22-7.
The listed molecular formula is C46H56N4O10.
The listed molecular weight is 825.0 g/mol.
methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate.
The source lists Vinkristin and Leurocristine.